乌斯尼克酸的肝毒性及其潜在机制
1Division of Biochemical Toxicology, National Center for Toxicological Research (NCTR)/U.S. FDA, Jefferson, Arkansas, USA.
概括
的代谢物乌斯尼克酸被推销用于减肥,但导致肝脏毒性. 本综述更新了对乌斯尼克酸肝毒性及其机制的理解.
科学领域:
- 自然产品 化学 化学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乌斯尼克酸是一种二次类代谢物,具有各种声称的治疗性质.
- 作为减肥补充剂销售的含乌斯尼克酸产品与肝毒性有关.
- 2001年美国FDA的行动凸显了人们对乌斯尼克酸引起的肝损伤的担忧.
研究的目的:
- 提供关于与乌斯尼克酸相关的肝毒性现有知识的综合总结.
- 专注于乌斯尼克酸诱导的肝毒性背后的假定机制.
- 以2008年以来发布的数据更新之前的审查.
主要方法:
- 关于乌斯尼克酸毒性的科学出版物的文献综述.
- 对与乌斯尼克酸相关的肝毒性病例报告数据的分析.
- 关于肝损伤的拟议机制的信息综合.
主要成果:
- 乌斯尼克酸与人类的严重肝损伤有关.
- 一些机制,包括氧化应激和线粒体功能障碍,涉及usnic酸肝毒性.
- 目前正在进行的研究继续阐明毒性的确切途径.
结论:
- 乌斯尼克酸存在肝毒性风险,需要仔细考虑其使用.
- 了解肝毒性机制对于风险评估和潜在的减轻策略至关重要.
- 需要进一步的研究,以充分描述乌斯尼克酸的安全性.
相关概念视频
Enhanced Elimination of Poison
498
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
498
Phase II Reactions: Acetylation Reactions
214
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
214
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
2° Amines to N-Nitrosamines: Reaction with NaNO2
4.2K
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
4.2K
Toxic Reactions: Overview
966
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
966
Anticholinesterase Agents: Poisoning and Treatment
845
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
845


